Last update 01 Nov 2024
SYL-1801
Last update 01 Nov 2024
Overview
Basic Info
Drug Type siRNA |
Synonyms- |
Target |
Mechanism NRARP inhibitors(NOTCH regulated ankyrin repeat protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with SYL-1801A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular AMD
Safety, Tolerability and Pharmacokinetic Profile of Different Doses of SYL1801 Ophthalmic Solution in Healthy Volunteers
100 Clinical Results associated with SYL-1801
Login to view more data
100 Translational Medicine associated with SYL-1801
Login to view more data
100 Patents (Medical) associated with SYL-1801
Login to view more data
100 Deals associated with SYL-1801
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Wet age-related macular degeneration | Phase 2 | CZ | 22 Nov 2022 | |
| Wet age-related macular degeneration | Phase 2 | PL | 22 Nov 2022 | |
| Wet age-related macular degeneration | Phase 2 | SK | 22 Nov 2022 | |
| Wet Macular Degeneration | Phase 2 | CZ | 22 Nov 2022 | |
| Wet Macular Degeneration | Phase 2 | PL | 22 Nov 2022 | |
| Wet Macular Degeneration | Phase 2 | SK | 22 Nov 2022 | |
| Choroidal Neovascularization | Phase 1 | ES | 17 Mar 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 2 | - | SYL1801 preservative-free formulation in Novelia® multidose eye dropper | drbbcdfdos(ruutdaxlxk) = fpwqklxxqq wvcrpuloyy (wxjkzecuxc ) View more | - | 23 Apr 2023 | ||
SYL1801 formulation in single unit dose glass vials | pkjcvffnzl(hjgcwmblrf) = ibmccqurfj kygvciplcp (gjmqklxrzh ) |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free